Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round

Chinese clinical stage biotechnology company InventisBio Inc. announced on Monday the closing of a US$70 million series C round of financing led by Chinese private equity firm Advantech Capital and CMB International Capital, a wholly-owned subsidiary of China Merchants Bank (CMB). Chinese investment management firm Pudong Innotek, and existing investors Lilly Asia Venture (LAV) and […]

Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network